RFK Jr.'s handpicked committee approves manufacture of peptides he uses
There's no human safety or efficacy data, but that no longer seems to matter.
The Food and Drug Administration (FDA) committee, handpicked by Robert F. Kennedy Jr., has voted to approve the removal of restrictions on manufacturing peptides for human use. This decision was announced during a panel meeting on Thursday, although votes on an additional three peptides are set to take place today. Despite the absence of substantial evidence regarding the safety and efficacy of these peptides, the decision was anticipated months prior.
Kennedy Jr., a prominent advocate for peptides, had taken deliberate actions to ensure this outcome.
Peptides, akin to proteins, are chains of amino acids, differing mainly in length - generally ranging from 10 to 20 amino acids, as opposed to proteins which can consist of hundreds or thousands. Some peptides, like insulin, are created by processing a protein into shorter fragments. These peptides interact with receptors that have evolved to send signals to cells based on their specific levels.
Written by urgent.news from Ars Technica Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
